Screening multiple samples with a single test gets more people diagnosed using fewer supplies. Two health policy researchers explain how it works and how it could help the US.
The science behind direct-to-consumer gut microbe testing is in its infancy. Here’s what you need to know if you’ve been tempted to get your microbiome analysed.
A molecular biologist explains who should get tested, how the tests work and what the US government is doing to make tests available during a rapidly changing crisis.
Healthcare workers in sub-Saharan Africa lack access to laboratory diagnostics and often have to guess which antibiotics to use for presumed infections.
Charles Chiu, University of California, San Francisco
Superfast DNA analysis is now being used to crack medical mysteries when physicians can’t figure out whether an infectious microbe is causing the disease.
We cannot end TB with century-old technologies and poor quality care. It is time to reinvent the way we are managing TB, and overcome our collective failures of the imagination.
Countries globally should adopt and adapt the World Health Organization’s new Essential Diagnostics List – as a key step in the management of all diseases.
Public health experts enlist the molecular biology tools that create genetically modified organisms – as well as the GMOs themselves – in the fight against emerging infectious diseases.
Labor’s shadow health minister Catherine King, said that the government has “cut bulk-billing payments for pathology and diagnostic imaging to make patients pay more”. Is that right?